Palvella Therapeutics (PVLA) Other Non-Current Assets (2015 - 2023)

Palvella Therapeutics (PVLA) has 9 years of Other Non-Current Assets data on file, last reported at $287000.0 in Q3 2023.

• Other Non-Current Assets for Q3 2023 came in at $287000.0, down 78.04% year-over-year; the trailing twelve-month figure through Sep 2023 was $287000.0 (down 78.04% YoY), and the FY2022 annual result was $1.4 million, down 52.86% from the prior year.
• Other Non-Current Assets fell to $287000.0 in Q3 2023 per PVLA's latest filing, from $1.1 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $11.5 million in Q2 2019 and troughed at $287000.0 in Q3 2023.
• A 5-year average of $2.9 million and a median of $2.4 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2019 and 2020: Other Non-Current Assets jumped 8806.98% in 2019, then sank 82.81% in 2020.
• A 5-year view of Other Non-Current Assets shows it stood at $3.1 million in 2019, then gained by 5.18% to $3.3 million in 2020, then slipped by 12.24% to $2.9 million in 2021, then slumped by 52.86% to $1.4 million in 2022, then tumbled by 79.04% to $287000.0 in 2023.
• Business Quant data shows PVLA's Other Non-Current Assets at $287000.0 in Q3 2023, $1.1 million in Q2 2023, and $1.3 million in Q1 2023.